Webinar on COVID-19 and diabetes

Simple item page
dc.contributor.authorFasanmade, O.A
dc.date.accessioned2021-09-23T11:47:41Z
dc.date.available2021-09-23T11:47:41Z
dc.date.issued2020-04-30
dc.descriptionConference paperen_US
dc.description.abstractAbout 10% of coronavirus-infected patients have diabetes as a comorbidity. It seems diabetes may not increase the risk of SARS-CoV-2 infection, but it promotes severe progression of disease in COVID-19 patients. Diabetes promotes severe progression in COVID-19 patients. Diabetes comorbidity is associated with significantly increased mortality (0.9% mortality for patients without comorbidity vs. 7.3% mortality for patients with diabetes) Diabetes with COVID-19 appears more blood glucose fluctuations, strengthen dynamic glucose monitoring is necessary Insulin IV injection should be the first-line treatment in severe and critical patients.en_US
dc.description.sponsorshipNovo Nordisken_US
dc.identifier.citationFasanmade OA. Webinar on COVID-19 and diabetes. 2020en_US
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/9583
dc.language.isoenen_US
dc.publisherNovo Nordisken_US
dc.subjectDiabetes mellitus,en_US
dc.subjectCOVID-19en_US
dc.subjectManagementen_US
dc.subjectPatientsen_US
dc.subjectResearch Subject Categories::MEDICINEen_US
dc.titleWebinar on COVID-19 and diabetesen_US
dc.typePresentationen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Webinar_COVID and Diabetes_Final_V2.pdf
Size:
1.01 MB
Format:
Adobe Portable Document Format
Description:
Powerpoint presentation
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medicine- Conference papers